resistance to semaglutide Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review | Pharmaceutical Research Ozempic and Insulin Resistance: How

Research has found: Reduced antioxidant enzyme activity in affected individuals Accumulation of pro-oxidant compounds in the brain over time D-BHB combats oxidative stress by: Neutralizing free radicals Enhancing the body's antioxidant defenses (e.g., increasing glutathione production) Regulating key protective genes Balancing Brain Excitability An overly excitable nervous system is commonly seen in individuals prone to sensory overload

Many insurance plans place GLP-1 meds in specialty drug categories with higher copays & strict approval requirements

It actively promotes the formation of new blood vessels, a process called angiogenesis, which delivers vital nutrients to damaged areas

Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity